Uniroyal Global Engineered Products, Inc. Reports Net Sales

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
67
Uniroyal Global Engineered Products, Inc. Reports Net Sales of $100,377,278 and Net Income of $4,499,664 or $0.24 per Diluted Share for the Fiscal Year Ended January 1, 2017

Financial Highlights for the Fiscal Year Ended January 1, 2017 versus Prior Year:

 *Net Sales increase 0.6% (3.6% ex-currency)  *Gross Margins expand to 22.8%  *Operating Income increases 11.1%   * Income before tax benefit increases 11.2%  *Diluted Earnings Per Common Share $0.24 versus $0.26 on lower tax benefit

SARASOTA, Fla., March 20, 2017 (GLOBE NEWSWIRE) -- Uniroyal Global Engineered Products, Inc. (OTCQB:UNIR)

Net Sales

Net Sales for the fiscal year increased to $100,377,278, a gain of $615,305 or 0.6% versus the prior year. Included in these figures is a negative currency translation of $2.9 million due to the continued weakness in the British Pound. Also, fiscal 2015 was a 53-week period which, on a comparable basis, benefited Net Sales approximately $500,000 as compared to this year which was a 52-week period.  Without the effect of currency rate exchange and the additional week of sales in 2015, Net Sales would have increased 4.1%. 

The Global Automotive Sector, representing 64.9% of total Net Sales, increased $3.9 million or 6.0% versus the prior year as a result of the Company being awarded several new programs both in Europe and domestically.  The new platforms and programs should also benefit the automotive sector in fiscal 2017. Before the negative currency translation, the increase in the Global Automotive Sector would have been $6.6 million or 10.1%.

The Industrial Sector declined $3.3 million or 9.4% in fiscal 2016 as major off-highway equipment manufacturers were impacted by a very challenging economic environment. Before the negative currency translation, the decrease in the Industrial Sector would have been $3.1 million or 8.6%.

Operating Income

Gross Profit margins improved to 22.8% versus 22.0% last year.  The margin improvement is due in part to the capital projects in Europe put in place last year specifically targeted to operating efficiencies and continued progress on our lean manufacturing and continuous improvement initiatives .

Operating Income was up sharply in 2016, increasing 11.1% versus the prior year to $8,046,665 or 8.0% of Net Sales, an increase of $807,124 from the $7,239,541 or 7.3% reported last year. Operating expenses were in line with the prior year. Spending on Research and Development projects remained robust in 2016 at $1,727,616 or 1.7% of Net Sales.

“Despite some major economic headwinds in 2016, we recorded significant operational improvement.  Our focus for 2017 will continue to be on the development of new products and technical improvement in automotive and industrial applications as well as capital spending initiatives to further enhance a strengthening in margins,” said Howard R. Curd, Chairman and Chief Executive Officer.

Net Income Available to Common Shareholders

Net Income before taxes increased $620,116 or 11.2% to $6,180,905 versus the $5,560,789 reported last year primarily due to the expansion of Operating Margins.

Net Income Available to Common Shareholders declined 9.1% to $4,499,664 versus the $4,952,156 reported last year.  Offsetting the improved operational performance was a significant decline in the tax benefit versus the previous year primarily related to the reduction in the Company’s U.S. deferred tax valuation allowance.

For further details, see the Consolidated Statements of Operations in the Company’s Form 10-K filed on March 20, 2017.  The Company will have comments on the year in an earning conference call on March 21, 2017 at 9:00 am (EST).  Persons wishing to access the conference call may do so by dialing 800-732-8711 (U.S.) and 913-312-0711 (International), and using the ID #2350165.  Howard F. Curd, President, will discuss our earnings on the call and will be available for questions. The call will also be available by logging on to www.uniroyalglobal.com  and accessing the webcast link ( https://public.viavid.com/player/index.php?id=123426 ) in the investor relations section. A replay of the conference call will be available beginning March 21, 2017 through June 21, 2017 by calling (844) 512-2921 (US) or (412) 317-6671 (International) and Pin #2350165.

About Uniroyal Global Engineered Products, Inc.:

Uniroyal Global Engineered Products, Inc . (UNIR) is a leading manufacturer of vinyl coated fabrics that are durable, stain resistant, cost-effective alternatives to leather, cloth and other synthetic fabric coverings. Uniroyal Global Engineered Products, Inc.’s revenue in 2016 was derived 65% from the automotive industry and approximately 35% from the recreational, industrial, indoor and outdoor furnishings, hospitality and health care markets. Our primary brand names include Naugahyde®, BeautyGard®, Flameblocker™, Spirit Millennium® , Ambla®, Amblon®, Velbex®, Cirroflex®, Plastolene® and Vynide®.

Forward-Looking Statements:

Except for statements of historical fact, certain information contained in this press release constitutes forward-looking statements, including, without limitation, statements containing the words “believe,” “expect,” “anticipate,” “intend,” “should,” “planned,” “estimated” and “potential” and words of similar import, as well as all references to the future. These forward-looking statements are based on Uniroyal Global Engineered Products, Inc.’s current expectations. The Company cautions investors that any forward-looking statements made by the Company are not guarantees of future performance and that a variety of factors could cause the Company´s actual results and experience to differ materially from the anticipated results or other expectations expressed in the Company´s forward-looking statements. The risks and uncertainties which may affect the operations, performance, development and results of the Company´s business include, but are not limited to, the following: uncertainties relating to economic conditions, uncertainties relating to customer plans and commitments, the pricing and availability of equipment, materials and inventories, currency fluctuations, technological developments, performance issues with suppliers, economic growth, delays in testing of new products, the Company’s ability to successfully integrate acquired operations, the Company’s dependence on key personnel, the Company’s ability to protect its intellectual property rights, the effectiveness of cost-reduction plans, rapid technology changes and the highly competitive environment in which the Company operates. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statement was made.

Uniroyal Global Engineered Products, Inc.  
Consolidated Statements of Operations  
                         
    Years Ended  
       
    January 1, 2017   January 3, 2016  
           
NET SALES   $ 100,377,278     $ 99,761,973    
           
COST OF GOODS SOLD     77,515,316       77,813,354    
           
Gross Profit     22,861,962       21,948,619    
           
OPERATING EXPENSES:          
Selling     5,078,706       5,201,199    
General and administrative     8,008,975       7,779,012    
Research and development     1,727,616       1,728,867    
OPERATING EXPENSES     14,815,297       14,709,078    
           
Operating Income     8,046,665       7,239,541    
           
OTHER EXPENSE:          
Interest and other debt related expense     (1,616,120 )     (1,613,391 )  
Other expense     (249,640 )     (65,361 )  
Net Other Expense     (1,865,760 )     (1,678,752 )  
           
INCOME BEFORE TAX BENEFIT     6,180,905       5,560,789    
           
TAX BENEFIT     (1,198,557 )     (2,193,054 )  
           
NET INCOME     7,379,462       7,753,843    
           
Preferred stock dividend     (2,879,798 )     (2,801,687 )  
           
NET INCOME AVAILABLE TO COMMON   SHAREHOLDERS   $ 4,499,664     $ 4,952,156    
           
EARNINGS PER COMMON SHARE:          
Basic     0.24       0.35    
Diluted     0.24       0.26    
WEIGHTED AVERAGE SHARES OUTSTANDING:        
Basic     18,828,378       14,334,485    
Diluted     18,869,709       19,040,032    
                   
Uniroyal Global Engineered Products, Inc.
Consolidated Balance Sheets
 
ASSETS   January 1, 2017   January 3, 2016
CURRENT ASSETS        
Cash and cash equivalents   $ 1,321,586     $ 1,910,112  
Accounts receivable, net     14,555,463       14,209,056  
Inventories, net     17,046,171       17,527,728  
Other current assets     2,485,213       2,891,007  
Related party receivable     25,456       23,298  
Total Current Assets     35,433,889       36,561,201  
                 
PROPERTY AND EQUIPMENT, NET     13,611,494       14,003,276  
OTHER ASSETS        
Intangible assets     3,133,564       3,534,936  
Goodwill     1,079,175       1,079,175  
Other long-term assets     5,410,375       3,095,414  
Total Other Assets     9,623,114       7,709,525  
                 
TOTAL ASSETS   $ 58,668,497     $ 58,274,002  
         
LIABILITIES AND STOCKHOLDERS' EQUITY        
CURRENT LIABILITIES        
Checks issued in excess of bank balance   $ 679,494     $ 322,307  
Lines of credit     16,799,592       16,577,279  
Current maturities of long-term debt     851,988       639,018  
Current maturities of capital lease obligations     368,718       489,978  
Accounts payable     7,331,213       7,592,510  
Accrued expenses     3,645,526       3,941,296  
Related party obligation     371,161       276,880  
Current portion of postretirement benefit liability - health and life     158,527       136,725  
Total Current Liabilities     30,206,219       29,975,993  
         
LONG-TERM LIABILITIES        
Long-term debt, less current portion     1,994,910       2,134,243  
Capital lease obligations, less current portion     856,171       1,469,317  
Related party lease financing obligations     2,162,151       2,164,682  
Long-term debt to related parties     2,826,907       4,449,243  
Postretirement benefit liability - health and life, less current portion     2,883,684       2,836,638  
Other long-term liabilities     838,308       975,781  
Total Long-Term Liabilities     11,562,131       14,029,904  
Total Liabilities     41,768,350       44,005,897  
         
STOCKHOLDERS' EQUITY        
Preferred units, Series A UEP Holdings, LLC, 200,000 units issued    and outstanding ($100 issue price)     617,571       617,571  
Preferred units, Series B UEP Holdings, LLC, 150,000 units issued    and outstanding ($100 issue price)     463,179       463,179  
Preferred stock, Engineered Products Acquisition Limited, 50 shares    issued and outstanding ($1.51 stated value)     75       75  
Common stock, 95,000,000 shares authorized ($.001 par value)    18,727,782 and 18,890,909 shares issued and outstanding as of    January 1, 2017 and January 3, 2016, respectively     18,728       18,892  
Additional paid-in capital     34,653,894       34,823,886  
Accumulated deficit     (17,174,814 )     (21,674,478 )
Accumulated other comprehensive income     (1,678,486 )     18,980  
Total Stockholders' Equity     16,900,147       14,268,105  
                 
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY   $ 58,668,497     $ 58,274,002  
                 

 

Uniroyal Global Engineered Products, Inc. Corporate Contact: Elizabeth Henson, 941-870-3950 LHenson@UniroyalGlobal.com or Uniroyal Global Engineered Products, Inc. Public Relations: TTC Group, Inc. Vic Allgeier, 646-290-6400 vic@ttcominc.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 234

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
TCL Tablets Arrive on BestBuy.com: What It Means

Updated Category News Views 11

Go Big or Go Home: TCL's Bold Move TCL just dropped a little bombshell that's gonna ripple through the electronics retail market—its tablets and smartphones are now bright and shiny on BestBuy.com. It's like standing at the craps table and before you know it, the stakes have just doubled. Why? Best Buy ain't some hole-in-the-wall spot. It's the premium electronics...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 345

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Formation Unveils First Solana Tokenized Securities Venue

Updated Category News Views 22

Well, here we go. Formation Securities is setting sail on the high seas of blockchain, aiming to operate a tokenized securities venue (TSV) on Solana. This isn't your garden-variety launch—it's a bold leap into a newer, faster-paced world of trading. Sure, you’ve heard about blockchains before, but this operation marries the traditional rigmarole of the stock market...

Continue Reading
Continuous Insulation Market Grows, Hits $67.74B by 2031

Updated Category News Views 19

Market Trends and Key Drivers Imagine riding a slow but steady bull market in insulation—sounds mundane, but the numbers don't lie. MarketsandMarkets™ had the scoop, predicting the Continuous Insulation Market will balloon from USD 56.98 billion in 2026 to USD 67.74 billion by 2031, putting down roots with a 3.5% CAGR. Now, you and I both know that when real estate...

Continue Reading
Tigo Energy Faces Class Action: Investor Deadline Looms

Updated Category News Views 5

Unpacking Tigo's Rollercoaster: Lawsuit & Market Reaction They sometimes say, "When it rains, it pours." For Tigo Energy, it’s been more a downpour than a drizzle. Here we are, chasing down what's going on with Tigo Energy (NASDAQ:TYGO), fresh off the heels of a class action fuss that's grabbed every investor's attention. If you've got a stake, or even a passing...

Continue Reading
O-I Glass Faces Class Action: Investor Implications

Updated Category News Views 130

O-I Glass in Hot Water Over Misleading Statements I'll tell you, nothing gets my goat quite like uncovering deceptive practices in the corporate world. It seems O-I Glass, Inc. (NYSE: OI), might have played a fast one with its shareholders. The company is staring down the barrel of a class action lawsuit from Schall, Brown & Schwartz LLP, alleging they weren't entirely...

Continue Reading
Photocure Navigates AssureMDx's Medicare Journey

Updated Category News Views 99

Aiming High with AssureMDx Photocure's got this bladder cancer test called AssureMDx that's at the center of its recent moves after acquiring Vesica Health a few months back. This isn't just any test; it's a urine-based, non-invasive way to snag an early look at bladder cancer. With the FDA's Breakthrough Device tag pinned on, they're not just dipping their toes in—this...

Continue Reading
AWS Boosts Agilix's AI Education in Sierra Leone

Updated Category News Views 99

Agilix Labs' Landmark Leap with AWS Just when you think you've got the grip on global education dynamics, a new wave hits your shores, this time courtesy of Agilix Labs and AWS. Agilix Labs snagged a grant from Amazon Web Services, carving a path that blends AI with educational equity in Sierra Leone. Now, if that doesn’t prick up investor ears or yank a few...

Continue Reading
Zabalafin Hydrogel: Promise in Treating Atopic Dermatitis

Updated Category News Views 7

Pioneering a New Path in Dermatology Treatment In the world of dermatology, finding a topical solution that tackles the full spectrum of atopic dermatitis (AD) is as rare as hens' teeth. But here's a twist—in a recent research paper gracing the Journal of Drugs in Dermatology, Alphyn Biologics sheds light on their unique contender, Zabalafin Hydrogel. This ain't your...

Continue Reading

Top 5 Most Recently Viewed Articles

Captain D's Expands Globally with New Franchise Agreement

Updated Category News Views 653

Captain D's Takes a Giant Leap into Global Expansion In a significant move for its global growth strategy, Captain D's, the leading fast-casual seafood restaurant in the nation, has signed a major franchise agreement aimed at establishing its brand in the UK. This new venture marks a noteworthy milestone as the company prepares to serve its renowned seafood offerings to a...

Continue Reading
Understanding Your Rights as an Alto Neuroscience Shareholder

Updated Category News Views 129

Understanding Your Rights as an Alto Neuroscience Shareholder Alto Neuroscience, Inc. (NASDAQ: ANRO) has recently been in the spotlight as shareholder rights issues arise. For those investors who acquired shares, it is important to understand the implications of these developments and the actions that may be available to you. Why Should Shareholders Take Action? As a...

Continue Reading
Taiwan Fund, Inc. Shares Key Stockholder Meeting Outcomes

Updated Category News Views 170

The Taiwan Fund, Inc. Announces Stockholders Meeting Results The Taiwan Fund, Inc. (TWN), a prominent closed-end investment entity, recently revealed the outcomes of its Annual Stockholders Meeting. This important event, focusing on the future direction of the Fund, showcased a solid commitment from investors as they participated in key voting processes. Board of...

Continue Reading
Canadian Solar Inc. Delivers Solid Q2 2025 Financial Results

Updated Category News Views 295

Strong Performance by Canadian Solar Canadian Solar Inc. (NASDAQ: CSIQ) has recently reported its impressive financial results for the second quarter. The highlights include an increase in solar module shipments, reflecting the company's ongoing advancement in the renewable energy sector. Second Quarter Highlights The second quarter showcased a 14% quarter-over-quarter...

Continue Reading
Otto Aviation Partners with Galorath for Enhanced Cost Estimation

Updated Category News Views 219

Otto Aviation Partners with Galorath for Enhanced Estimation In a groundbreaking move, Otto Aviation has made a strategic decision to standardize its operations on Galorath's AI-powered estimation platform. This collaboration is set to significantly enhance Otto's pricing strategies as it ventures into sustainable aerospace projects, aiming to revolutionize the future of...

Continue Reading